Washington [US], October 21 (ANI): According to research results presented at the IDWeek Conference in Washington, starting antiretroviral treatment (ART) early in the course of HIV infection when the immune system is stronger results in better long-term health outcomes compared to delayed ART.
Washington [US], October 8 (ANI): An epigenetics drug currently being used for the treatment of blood cancers and rare sarcomas can stop the growth of bladder cancer by activating the immune system, reports a new study in mice. The drug is now being tested in a national clinical trial for patients with late-stage bladder cancer.
Washington [US], March 27 (ANI): New ways to treat seasonal asthma has been studied by researchers from Indiana University School of Medicine Department of Microbiology and Immunology recently.
Washington [US], March 22 (ANI): Researchers from Indiana University School of Medicine Department of Microbiology and Immunology have studied new ways to treat seasonal asthma.
New Delhi [India], January 8 (ANI): Covaxin manufacture Bharat Biotech on Saturday said that the booster dose trials have shown "promising results" of long-term safety with "no serious adverse events".
Washington [US], December 25 (ANI): Scientists have now developed a method that for the first time allows these specific immune cells to be genetically manipulated under physiological conditions in an efficient and uncomplicated manner.
Tokyo [Japan], December 18 (ANI): Scientists from Japan have discovered a fundamental part of the immune system's long-term memory, detailing how to design better vaccines for diseases, ranging from COVID-19 to malaria.
Tokyo [Japan], December 17 (ANI): Experts in Japan have identified a fundamental part of the immune system's long-term memory, providing a useful new detail in the pursuit to design better vaccines for diseases, ranging from COVID-19 to malaria.
Washington [US], September 7 (ANI): COVID-19 patients have different immune responses that lead to disease outcomes ranging from asymptomatic SARS-CoV-2 infection to death. After examining the blood samples from nearly 200 COVID-19 patients, researchers have uncovered underlying metabolic changes that regulate how immune cells react to the disease.